Craig-Hallum analyst Jonathan Komp upgrades SciPlay (NASDAQ:SCPL) from Hold to Buy and raises the price target from $14 to $17.
Where 2seventy bio Stands With Analysts
Within the last quarter, 2seventy bio (NASDAQ:TSVT) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…